rct
    2008

    Effects of nattokinase on blood pressure: a randomized, controlled trial

    Kim JY, Gum SN, Paik JK

    Published in Hypertension Research

    Key Findings

    Eight weeks of nattokinase 2000 FU/day lowered systolic blood pressure by 5.6 mmHg and diastolic by 2.8 mmHg versus placebo in pre-hypertensive adults.

    Conclusions

    Clinically modest antihypertensive effect.

    Limitations

    Short duration, single centre.

    Supplements Studied

    Nattokinase lowered systolic blood pressure by 5.6 mmHg versus placebo in pre-hypertensive adults.

    Outcomes Measured

    Blood Pressure Regulation

    Nattokinase reduced systolic blood pressure by 5.6 mmHg versus placebo.

    Related Health Concerns

    Elevated Blood Pressure

    Study Details

    Year:2008
    Sample Size:86
    Duration:8 weeks
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.